0001562180-18-004456.txt : 20181107
0001562180-18-004456.hdr.sgml : 20181107
20181107181859
ACCESSION NUMBER: 0001562180-18-004456
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181105
FILED AS OF DATE: 20181107
DATE AS OF CHANGE: 20181107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Orticerio Ernest
CENTRAL INDEX KEY: 0001724369
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38319
FILM NUMBER: 181167711
MAIL ADDRESS:
STREET 1: C/O QUANTERIX CORPORATION
STREET 2: 113 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quanterix Corp
CENTRAL INDEX KEY: 0001503274
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 208957988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 113 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-301-9400
MAIL ADDRESS:
STREET 1: 113 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-11-05
false
0001503274
Quanterix Corp
QTRX
0001724369
Orticerio Ernest
C/O QUANTERIX CORPORATION,
113 HARTWELL AVENUE
LEXINGTON
MA
02421
false
true
false
false
SVP Finance and Corporate Dev
Common Stock
2018-11-05
4
M
false
10000.00
2.28
A
63802.00
D
Common Stock
2018-11-05
4
S
false
10000.00
17.124
D
53802.00
D
Common Stock
2018-11-07
4
M
false
1171.00
2.28
A
54973.00
D
Common Stock
2018-11-07
4
S
false
1171.00
16.50
D
53802.00
D
Common Stock
2018-11-07
4
M
false
8829.00
2.28
A
62631.00
D
Common Stock
2018-11-07
4
S
false
8829.00
16.5261
D
53802.00
D
Stock Option (Right to Buy)
2.28
2018-11-05
4
M
false
10000.00
0.00
D
2022-02-03
Common Stock
10000.00
11670.00
D
Stock Option (Right to Buy)
2.28
2018-11-07
4
M
false
8829.00
0.00
D
2022-02-03
Common Stock
8829.00
2841.00
D
Stock Option (Right to Buy)
2.28
2018-11-07
4
M
false
1171.00
0.00
D
2022-02-03
Common Stock
1171.00
1670.00
D
Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.
This transaction was executed in multiple trades at prices ranging from $17.10 to $17.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $16.50 to $16.69. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
All shares underlying the option have vested.
/s/ Brian Keane, as Attorney-in-Fact
2018-11-07